Neural network dysfunction in bipolar depression: Clues from the efficacy of lamotrigine

Biochemical Society Transactions

Volumn 37, Issue 5, 2009, Pages 1080-1084

  Large, Charles H ^a   Di Daniel, Elena ^b   Li, Xingbao ^c   George, Mark S ^c,d  

^a GSK   (Italy)

^b GLAXOSMITHKLINE   (United Kingdom)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

Bipolar depression; Functional magnetic resonance imaging (fMRI); Gamma oscillation; Lamotrigine; Transcranial magnetic stimulation (TMS)

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3; LAMOTRIGINE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C;

BIPOLAR DEPRESSION; BRAIN CORTEX; CONFERENCE PAPER; DRUG EFFICACY; HAMILTON SCALE; HUMAN; IN VITRO STUDY; NERVE CELL NETWORK; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRANIAL MAGNETIC STIMULATION;

ANIMALS; ANTICONVULSANTS; BIPOLAR DISORDER; HUMANS; NERVE NET; TREATMENT OUTCOME; TRIAZINES;

RATTUS;

EID: 70350168436     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0371080     Document Type: Conference Paper

References (52)

1. Bachmann, R.F., Schloesser, R.J., Gould, T.D. and Manji, H.K. (2005) Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics. Mol. Neurobiol. 32, 173-202
2. Schloesser, R.J., Huang, J., Klein, P.S. and Manji, H.K. (2008) Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology 33, 110-133
3. Du, J., Creson, T.K., Wu, L.J., Ren, M., Gray, N.A., Falke, C., Wei, Y., Wang, Y., Blumenthal, R., Machado-Vieira, R. et al. (2008) The role of hippocampal GluR1 and GluR2 receptors in manic-like behavior. J. Neurosci. 28, 68-79
4. Manji, H.K., Moore, G.J. and Chen, G. (2001) Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilizers. Br. J. Psychiatry Suppl. 41, s107-s119
5. Ketter, T.A., Manji, H.K. and Post, R.M. (2003) Potential mechanisms of action of lamotrigine in the treatment of bipolar disorders. J. Clin. Psychopharmacol. 23, 484-495
6. Xie, X. and Hagan, R.M. (1998) Cellular and molecular actions of lamotrigine: possible mechanisms of ef.cacy in bipolar disorder. Neuropsychobiology 38, 119-130
7. Large, C.H., Webster, E.L. and Goff, D.C. (2005) The potential role of lamotrigine in schizophrenia. Psychopharmacology 181, 415-436
8. Ketter, T.A., Wang, P.W., Becker, O.V., Nowakowska, C. and Yang, Y.S. (2003) The diverse roles of anticonvulsants in bipolar disorders. Ann. Clin. Psychiatry 15, 95-108
9. Weisler, R.H., Cutler, A.J., Ballenger, J.C., Post, R.M. and Ketter, T.A. (2006) The use of antiepileptic drugs in bipolar disorders: a review based on evidence from controlled trials. CNS Spectr. 11, 788-799
10. Calabrese, J.R., Bowden, C.L., Sachs, G.S., Ascher, J.A., Monaghan, E. and Rudd, G.D. (1999) A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J. Clin. Psychiatry 60, 79-88
11. Geddes, J.R., Calabrese, J.R. and Goodwin, G.M. (2009) Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br. J. Psychiatry 194, 4-9
12. Goodwin, G.M., Bowden, C.L., Calabrese, J.R., Grunze, H., Kasper, S., White, R., Greene, P. and Leadbetter, R. (2004) A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J. Clin. Psychiatry 65, 432-441
13. Calabrese, J.R., Suppes, T., Bowden, C.L., Sachs, G.S., Swann, A.C., McElroy, S.L., Kusumakar, V., Ascher, J.A., Earl, N.L., Greene, P.L. and Monaghan, E.T. (2000) A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J. Clin. Psychiatry 61, 841-850
14. Hurley, S.C. (2002) Lamotrigine update and its use in mood disorders. Ann. Pharmacother. 36, 860-873
15. Herman, E. (2004) Lamotrigine: a depression mood stabiliser. Eur. Neuropsychopharmacol. 14 (Suppl. 2), S89-S93
16. Ketter, T.A. and Calabrese, J.R. (2002) Stabilization of mood from below versus above baseline in bipolar disorder: a new nomenclature. J. Clin. Psychiatry 63, 146-151
17. + channels in rat hippocampal neurones. Pflüger's Arch. 430, 437-446
18. Manganotti, P., Bongiovanni, L.G., Zanette, G., Turazzini, M. and Fiaschi, A. (1999) Cortical excitability in patients after loading doses of lamotrigine: a study with magnetic brain stimulation. Epilepsia 40, 316-321
19. Tergau, F., Wischer, S., Somal, H.S., Nitsche, M.A., Mercer, A.J., Paulus, W. and Steinhoff, B.J. (2003) Relationship between lamotrigine oral dose, serum level and its inhibitory effect on CNS: insights from transcranial magnetic stimulation. Epilepsy Res. 56, 67-77
20. Li, X., Teneback, C.C., Nahas, Z., Kozel, F.A., Large, C., Cohn, J., Bohning, D.E. and George, M.S. (2004) Interleaved transcranial magnetic stimulation/functional MRI con.rms that lamotrigine inhibits cortical excitability in healthy young men. Neuropsychopharmacology 29, 1395-1407
21. Paulus, W., Classen, J., Cohen, L.G., Large, C.H., Di Lazzaro, V., Nitsche, M., Pascual-Leone, A., Rosenow, F., Rothwell, J.C. and Ziemann, U. (2008) State of the art: pharmacologic effects on cortical excitability measures tested by transcranial magnetic stimulation. Brain Stimulat. 1, 151-163
22. Li, X., George, M.S., Large, C.H., Ricci, R., Johnson, K., Anderson, B., Nahas, Z. and Bohning, D.E. (2006) Using motor and prefrontal cortex interleaved transcranial magnetic stimulation (TMS) BOLD fMRI to compare the mechanism of action of lamotrigine to valproic acid in normal volunteers, 45th American College of Neuropsychopharmacology Annual Meeting, Hollywood, FL, U.S.A., P.44 (Abstract)
23. Haldane, M., Jogia, J., Cobb, A., Kozuch, E., Kumari, V. and Frangou, S. (2007) Changes in brain activation during working memory and facial recognition tasks in patients with bipolar disorder with Lamotrigine monotherapy. Eur. Neuropsychopharmacol. 18, 48-54
24. Aldenkamp, A.P. and Baker, G. (2001) A systematic review of the effects of lamotrigine on cognitive function and quality of life. Epilepsy Behav. 2, 85-91
25. Kahkonen, S., Wilenius, J., Komssi, S. and Ilmoniemi, R.J. (2004) Distinct differences in cortical reactivity of motor and prefrontal cortices to magnetic stimulation. Clin. Neurophysiol. 115, 583-588
26. Fisahn, A. (2005) Kainate receptors and rhythmic activity in neuronal networks: hippocampal gamma oscillations as a tool. J. Physiol. 562, 65-72
27. Mann, E.O. and Paulsen, O. (2005) Mechanisms underlying gamma (′40 Hz′) network oscillations in the hippocampus: a mini-review. Prog. Biophys. Mol. Biol. 87, 67-76
28. Gloveli, T., Dugladze, T., Saha, S., Monyer, H., Heinemann, U., Traub, R.D., Whittington, M.A. and Buhl, E.H. (2005) Differential involvement of oriens/pyramidale interneurones in hippocampal network oscillations in vitro. J. Physiol. 562, 131-147
29. Benes, F.M., Lim, B., Matzilevich, D., Walsh, J.P., Subburaju, S. and Minns, M. (2007) Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars. Proc. Natl. Acad. Sci. U.S.A. 104, 10164-10169
30. De Sarno, P., Li, X. and Jope, R.S. (2002) Regulation of Akt and glycogen synthase kinase-3β phosphorylation by sodium valproate and lithium. Neuropharmacology 43, 1158-1164
31. Phiel, C.J. and Klein, P.S. (2001) Molecular targets of lithium action. Annu. Rev. Pharmacol. Toxicol. 41, 789-813
32. Chen, G., Huang, L.D., Jiang, Y.M. and Manji, H.K. (1999) The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3. J. Neurochem. 72, 1327-1330
33. Werstuck, G.H., Kim, A.J., Brenstrum, T., Ohnmacht, S.A., Panna, E. and Capretta, A. (2004) Examining the correlations between GSK-3 inhibitory properties and anti-convulsant efficacy of valproate and valproate-related compounds. Bioorg. Med. Chem. Lett. 14, 5465-5467
34. Di Daniel, E., Cheng, L., Maycox, P.R. and Mudge, A.W. (2006) The common inositol-reversible effect of mood stabilizers on neurons does not involve GSK3 inhibition, myo-inositol-1-phosphate synthase or the sodium-dependent myo-inositol transporters. Mol. Cell. Neurosci. 32, 27-36
35. Williams, R.S., Cheng, L., Mudge, A.W. and Harwood, A.J. (2002) A common mechanism of action for three mood-stabilizing drugs. Nature 417, 292-295
36. Bijur, G.N., De Sarno, P. and Jope, R.S. (2000) Glycogen synthase kinase-3β facilitates staurosporine- and heat shock-induced apoptosis: protection by lithium. J. Biol. Chem. 275, 7583-7590
37. Lenox, R.H., Watson, D.G., Patel, J. and Ellis, J. (1992) Chronic lithium administration alters a prominent PKC substrate in rat hippocampus. Brain Res. 570, 333-340
38. Watson, D.G. and Lenox, R.H. (1996) Chronic lithium-induced down-regulation of MARCKS in immortalized hippocampal cells: potentiation by muscarinic receptor activation. J. Neurochem. 67, 767-777
39. Szabo, S.T., Machado-Vieira, R., Yuan, P., Wang, Y., Wei, Y., Falke, C., Cirelli, C., Tononi, G., Manji, H.K. and Du, J. (2009) Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of mania. Neuropharmacology 56, 47-55
40. Zarate, Jr, C.A., Singh, J.B., Carlson, P.J., Quiroz, J., Jolkovsky, L., Luckenbaugh, D.A. and Manji, H.K. (2007) Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study. Bipolar Disord. 9, 561-570
41. Einat, H., Yuan, P., Gould, T.D., Li, J., Du, J., Zhang, L., Manji, H.K. and Chen, G. (2003) The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J. Neurosci. 23, 7311-7316
42. Yuan, P.X., Huang, L.D., Jiang, Y.M., Gutkind, J.S., Manji, H.K. and Chen, G. (2001) The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth. J. Biol. Chem. 276, 31674-31683
43. Di Daniel, E., Mudge, A.W. and Maycox, P.R. (2005) Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons. Bipolar Disord. 7, 33-41
44. McLaughlin, S. and Murray, D. (2005) Plasma membrane phosphoinositide organization by protein electrostatics. Nature 438, 605-611
45. Berridge, M.J., Downes, C.P. and Hanley, M.R. (1989) Neural and developmental actions of lithium: a unifying hypothesis. Cell 59, 411-419
46. Hallcher, L.M. and Sherman, W.R. (1980) The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J. Biol. Chem. 255, 10896-10901
47. McGrath, B.M., Greenshaw, A.J., McKay, R., Slupsky, C.M. and Silverstone, P.H. (2007) Unlike lithium, anticonvulsants and antidepressants do not alter rat brain myo-inositol. Neuroreport 18, 1595-1598
48. Du, J., Quiroz, J., Yuan, P., Zarate, C. and Manji, H.K. (2004) Bipolar disorder: involvement of signaling cascades and AMPA receptor trafficking at synapses. Neuron Glia Biol. 1, 231-243
49. Du, J., Suzuki, K., Wei, Y., Wang, Y., Blumenthal, R., Chen, Z., Falke, C., Zarate, Jr, C.A. and Manji, H.K. (2007) The anticonvulsants lamotrigine, riluzole, and valproate differentially regulate AMPA receptor membrane localization: relationship to clinical effects in mood disorders. Neuropsychopharmacology 32, 793-802
50. Maeng, S., Zarate, Jr, C.A., Du, J., Schloesser, R.J., McCammon, J., Chen, G. and Manji, H.K. (2008) Cellular mechanisms underlying the antidepressant effects of ketamine: role of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol. Psychiatry 63, 349-352
51. Tremblay, L.K., Naranjo, C.A., Graham, S.J., Herrmann, N., Mayberg, H.S., Hevenor, S. and Busto, U.E. (2005) Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe. Arch. Gen. Psychiatry 62, 1228-1236
52. Vengeliene, V., Heidbreder, C.A. and Spanagel, R. (2007) The effects of lamotrigine on alcohol seeking and relapse. Neuropharmacology 53, 951-957